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Tbjectives: Strategies to recover myocardium in therapeutically unresponsive pa-
ients are again under scrutiny, including techniques developed in the pioneering
ays of cardiothoracic surgery such as retroperfusion via the coronary sinus—the
eck procedure. An underestimated aspect of retroperfusion is the formation of new
essels. This early observation of neoangiogenesis may be an important mechanism
n observed benefits. We hypothesized that periodic pressure elevation in coronary
eins induces an analogy to shear stress angiogenic pulses by activating venous
ndothelium. Pulsatile stretch on venous endothelium can be achieved easily by a
ressure-controlled intermittent balloon blockade of the coronary sinus outflow.
ethods: Three hours of myocardial ischemia was induced in 12 pigs. Pressure-
ontrolled intermittent coronary sinus occlusion was applied in 6 animals 15
inutes after occlusion of the left anterior descending coronary artery. Postmortem
yocardial specimens were taken, and heme oxygenase-1, vascular endothelial
rowth factor gene expression, and hypoxia-induced factor activity were measured.
esults: As compared with controls, treated animals released an angiogenic pulse by
4-fold increase of heme oxygenase-1 gene expression in the infarct area (P 
001), together with a 2.5-fold enhanced transcription of vascular endothelial growth
actor in the infarct (P  .006), border (P  .002), and remote (P  .02) areas,
hereas hypoxia-induced factor activity was similar in both groups. A significant
orrelation (P  .01) of the achieved coronary sinus pressure elevation and gene
xpression was found.
onclusions: Mechanotransduction of pulsatile stretch on coronary venous endo-
helium by pressure-controlled intermittent coronary sinus occlusion induces heme
xygenase-1 and vascular endothelial growth factor gene expression, leaving the
schemic pathway of the hypoxia-induced factor activity unchanged. This cascade of
olecular events closes the argument gap to historical reports of the Beck procedure
n revascularization and myocardial salvage.
oday, in the advent of percutaneous techniques, cardiac tissue regeneration to
treat therapeutically unresponsive patients remains one of the important
fields in cardiac research. Many of the methods developed by our surgical
orefathers are again under scrutiny because alternative methods are increasingly
sed by cardiologists to induce regeneration and recovery of the failing heart.
lthough many of these pioneering techniques were abandoned because of the fast
rack of early technological development in cardiothoracic surgery in days past, new
nterest on the repair mechanism, stem cell research, cell transplantation, and
ethods to accomplish improved homing, focus interest on the historical perspec-ive.1,2 Recently Kanamori and associates3 reported on a hybrid surgical angiogen-
he Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 6 1581
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1
CSPsis using cardio-omentopexy, a method introduced as early
s 1936 by O‘Shaughnessy.4 One of the pioneers in the use
f cardio-omentopexy was Claude Beck, who also devel-
ped a clinically applicable surgical retroperfusion tech-
ique using the coronary sinus route. Although experimen-
al and clinical results showed considerable improvements
n many of the individuals treated, the effects of this pro-
edure on the reversal of myocardial ischemia may have
een misinterpreted and ever since have been the subject of
ontroversial debate.
There is no doubt, considering everyday surgical prac-
ice, that reversal of coronary flow can protect the globally
rrested myocardium and even start the heart beating during
etroperfusion of warm blood at the end of aortic clamping.
owever, the question remains whether retroperfusion of
rterial blood in the regionally ischemic beating heart is the
ause of improvements observed.
The salvage potential of different retroperfusion tech-
iques originating from Beck‘s idea have been established
n a meta-analysis showing an inverse relationship between
chieved coronary sinus pressure (duration and elevation of
he coronary venous pressure during retroperfusion) and
nfarct size. This obvious relationship between the hemo-
ynamic force of periodic elevation of coronary venous
ressure on jeopardized myocardium and salvage has never
een appreciated, because the scientific mainstream associ-
ted beneficial effects of retroperfusion techniques to the
elivery of oxygenated blood.5 In this context, it is note-
orthy that the fact that myocardial salvage less likely
ccurs in Krogh-like diffusion cylinders around major ret-
operfused cardiac veins, but rather in border zones of
eprived myocardium, has never been questioned.
An important implication to solve this question is an
bservation made in a historical report by Hahn and Kim,6
tudying the Beck procedure, on long-term histologic
hanges of ischemic myocardium describing “many vascu-
ar channels distal to the occluded artery.” This observation
s of special interest and can be interpreted as neoangiogen-
sis. Concerning this obvious form of revascularization and
yperplasia of veins subjected to permanent reversal of
ow, the authors commented “that pulsatile pressure might
e the origin of these changes,” but that their historical
Abbreviations and Acronyms
2-M  2-microglobulin
HIF  hypoxia-induced factor
HO  heme oxygenase
LAD  left anterior descending coronary artery
PICSO pressure-controlled intermittent coronary
sinus occlusion
VEGF  vascular endothelial growth factortudy was unable to answer this question.6 t
582 The Journal of Thoracic and Cardiovascular Surgery ● JunAn integral component of the healing process after myo-
ardial infarction is the development of neoangiogenesis in
he myocardial infarct zone. Under normal circumstances,
he contribution of neoangiogenesis to the infarct-bed cap-
llary network is insufficient to keep pace with the tissue
rowth required for contractile compensation. Several meth-
ds have been postulated to induce neoangiogenesis to
ecover the structural and functional integrity of jeopardized
yocardium, but they remain a matter of debate.7
Evidently, Hahn and Kim‘s observation6 corresponds to
 form of neovascularization. It can be speculated whether
ulsatile pressure and/or other factors such as cytokine
elease might be involved.
Alternatively, the induction of genomic reprogramming
or cell survival, including cytoprotective genes via envi-
onmental changes such as mechanotransduction and acti-
ation of endothelium, are well established.8,9 Since it is
uggested that mechanical factors play a major role in
oronary angiogenesis,10-12 a biomechanical intervention
hould affect myocardial gene expression. It has been
hown that shear stress on the endothelium during ischemia
nduces signaling pathways leading to the formation of
ollaterals via pressure and flow gradients within the mi-
rocirculation and consequently to increased shear stress.
ur objective in this study was to use this otherwise not
nfluenceable natural mechanism intentionally with periodic
enous pressure elevation (pressure-controlled intermittent
oronary sinus occlusion—PICSO) in a pig model and to
ink it to known effects of retroperfusion like myocardial
alvage and Hahn and Kim‘s histologic observation of an
nduction of vessel growth.
To study the molecular cascade induced by mechanical
orce on endothelium, we focus on two functionally inter-
elated, proangiogenic genes in porcine myocardium: heme
xygenase (HO)-1, a molecule also known to be involved
n vasodilation, and vascular endothelial growth factor
VEGF). We anticipate that the microcirculatory stretch
nduced by PICSO is associated with the upregulation of
O-1 and VEGF mRNA, two markers expressed by the
ctivated endothelium, whereas the ischemic pathway via
ypoxia-induced factor (HIF) activity should remain un-
hanged. The purpose of this study was to close the gap
etween the experience in coronary sinus retroperfusion of
he past and our hypothesis that pulsatile pressure in the
oronary venous circulation may play a role in myocardial
alvage and neoangiogenesis.
aterials and Methods
See additional text online.)*
The animals were given systemic anticoagulation with a hep-
rin sulfate intravenous bolus (1000 IU) before preparation of the
reat neck vessels. The heart was exposed through an incision in
he fifth left intercostal space, part of the fifth rib was removed, and
he pericardium was cut open and sutured to the chest wall. The
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Peart was then suspended in a pericardial cradle. The left anterior
escending artery (LAD) and the circumflex artery were carefully
issected free of their venae comitans with the help of local immo-
ilization normally used in beating heart surgery. The LAD was then
ncircled with a vascular snare distal to the major diagonal branches.
efore catheterization of the coronary sinus, a heparin sulfate bolus
20,000 IU, intravenous) was administered. A double-lumen 7F cath-
ter with a curved tip (Contract Medical International GmbH,
resden, Germany) was inserted from the left internal jugular vein
nd placed in a stable position with the balloon approximately 25 mm
nside the coronary sinus. Then the hemiazygos vein draining the
oronary sinus was occluded. The correct balloon location and com-
lete occlusion of the coronary sinus were confirmed radiographically
uring one occlusion cycle. The coronary sinus pressure was moni-
ored and recorded continuously through the central lumen of the
atheter. The stable position of the balloon during occlusion and
elease was maintained through monitoring the balloon pressure.
uring the entire experiment, all measurements were recorded on a
omputerized data acquisition system for biological signals.
tudy Protocol
ll animals received human care in compliance with the “Princi-
les of Laboratory Animal Care,” formulated by the Institute of
aboratory Animal Resources and the “Guide for the Use of
aboratory Animals,” prepared by the National Academy of Sci-
nces and published by the National Institutes of Health (Pub No.
6-23, revised 1985). A series of 12 pigs (6 PICSO treated vs 6
ontrols) was subjected to 3 hours of ischemia. The previously
laced vascular snare around the left anterior descending artery
LAD) was occluded, with a 3-hour period of acute anterior wall
schemia. Six pigs received no further intervention (control group).
n the study group, PICSO intervention was started 15 minutes
fter LAD occlusion and continued throughout the entire experi-
ent. The pump cycles ranged from 5 seconds of inflation/3
econds of deflation to 10 seconds of inflation/5 seconds of defla-
ion. In a subset of animals (4 PICSO-treated/2 controls), global
all motion was determined in regular intervals with epicardial
-dimensional echocardiography. Hemodynamic data were re-
orded throughout the experiment.
ICSO
 coronary sinus pressure–controlled feedback system was devel-
ped to produce intermittent coronary sinus occlusion and has
een reported elsewhere (Austrian Research Center, Seibersdorf,
ustria). Continuous measurements of the coronary sinus pressure
nd an effective feedback control allowed a physiologic pressure
ncrease without reactive and permanent coronary inflow
mpedance.13
(See additional text online.)†
nternal End-diastolic and End-systolic Diameters
wo-dimensional echocardiograms were recorded on a cine loop
o that at least 2 or 3 measurements of the cavity and myocardium
ould be taken in cross sections and long-axis views. Left
entricular end-systolic and end-diastolic volumes were calcu-
ated from 2-dimensional echocardiograms by the area-length
ethod by the following formula: V  (8/3) · (A 2/lL ),max max
here V presents the volume of the ventricle, Amax is the maximal t
The Journal of Thoracicross-sectional area of the ventricle at the midpapillary muscle
evel, and Lmax expresses the maximal length of the ventricle
etween the mitral valve and apex. End-diastolic (EDV) and
nd-systolic volumes (ESV) were calculated by measuring the
orresponding end-diastolic and end-systolic Amax and Lmax.E1
jection fraction was calculated as (EDV  ESV)/EDV and ex-
ressed as percentage. Heart rate was monitored continuously. The
ecordings were evaluated by an observer blinded to the treatment
roup.
NA Extraction and cDNA Synthesis
t the end of each experiment, the animal was put to death and the
eart was removed quickly. After being rinsed with a cold 0.9%
odium chloride solution, the heart was dipped in liquid nitrogen
or approximately 20 seconds. For the RNA extraction small
ieces of tissue, representing the infarct area, the peri-infarct
order area, and the remote noninfarcted myocardium, were cut
rom frozen slices of infarcted pig hearts. These small pieces of pig
eart tissue (approximately 150 mg [wet weight]) were homoge-
ized in a tissue grinder, total RNA was extracted with Tri-
eagent (Molecular Research Center, Cincinnati, Ohio) according
o the manufacturer’s protocol, and 1 g of the isolated total RNA
as reverse transcribed.
rimers and Taq Man Probes
rimers and FAM-labeled Taq Man probes for HO-1 and VEGF
ere designed according to GenBank: accession numbers X60677
nd AF461807, respectively. Primers were designed to exclude the
mplification of genomic DNA. Target transcripts were normal-
zed to the endogenous housekeeping transcript 2-microglobulin
2-M). Primers and FAM-labeled Taq Man probe were designed
ccording to GenBank: accession number L13854.
(See additional text online.)‡
eal-time Quantitative Reverse
ranscriptase–Polymerase Chain Reaction
ifty nanograms of cDNA was amplified in a Gene Amp 5700
equence Detection System (Applied Biosystems, Foster City,
alif), and polymerase chain reaction results were analyzed with
he Sequence detector 1.6 program (Perkin-Elmer, Inc, Waltham,
ass). The amount of target was normalized to the endogenous
eference 2-M. Analyses were performed in triplicate.
ssay of HIF-1 Activity: Electrophoretic Mobility
hift Assay
yocardial specimens (200 mg) from remote, border, and in-
arcted areas were washed twice with ice-cold phosphate-buffered
aline containing 1 g/mL leupeptin (Valeant Pharmaceuticals
nternational, Costa Mesa, Calif), 1 g/mL aprotinin (ICN Phar-
aceuticals), and 0.5 mmol/L phenylmethylsulfonylfluoride
Sigma Chemical Company, St Louis, Mo). Tissue samples were
ransferred into a tissue grinder and homogenized in 5  volume
old extraction buffer consisting of 20 mmol/L HEPES (pH 7.9),
.45 mol/L NaCl, 1 mmol/L ethylenediaminetetraacetic acid, 1
g/mL leupeptin, 1 g/mL aprotinin, and 0.5 mmol/L phenyl-
ethylsulfonylfluoride (Sigma). Thereafter, the homogenate wasransferred to an Eppendorf tube and incubated on ice on a rocking
and Cardiovascular Surgery ● Volume 133, Number 6 1583
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1
CSPlatform for 10 minutes. The samples were then sonicated on ice
n a bath-type sonicator (2  60 seconds), and extracted material
as recovered as the supernatant after centrifugation (12,500g for
0 minutes at 4oC). The supernatants were diluted with equal
olumes of an ice-cold buffer consisting of 20 mmol/L HEPES,
.1 mol/L KCl, 0.2 mmol/L ethylenediaminetetraacetic acid, 20%
v/v) glycerol, and 0.5 mmol/L dithiothreitol and immediately
rozen in liquid nitrogen. Protein content of the recovered extracts
as determined against solutions with increasing concentrations of
ovine serum albumin standard using a modified Bradford protein
ssay (Bio-Rad Laboratories, Hercules, Calif). The extracts re-
rieved from myocardial specimens were subjected to the DNA
inding reaction with the HIF-1 specific oligonucleotide probe.
(See additional text online.)§
tatistical Analysis
ata are given as mean  standard deviation except where indi-
ated. The effect of coronary sinus occlusion on gene expression
as analyzed by the Student 2-sample t test on log-base-2 trans-
ormed data. The course of hemodynamic parameters for each pig
uring LAD occlusion was summarized by computing the individ-
al average value as summary measure.13 Groups were then com-
ared by analysis of covariance, adjusting for individual baseline
alues.14 Similarly, functional parameters were compared between
roups by analysis of covariance of the individual average values,
djusting for individual baseline values. Changes from baseline
alues within the groups were assessed by paired t test. Correlation
nalysis was performed by computing the Pearson linear correla-
ion coefficient.
esults
emodynamics
ntermittent coronary sinus occlusion resulted in a gradual
ncrease of the coronary venous pressure, reaching a plateau
fter a few seconds. After release of the outflow impedance,
ressures returned to control values almost immediately.
See additional text online.)¶
Comparison between groups showed that PICSO led to a
trong increase of the systolic coronary sinus pressure (57 
4.2 mm Hg), whereas the systolic coronary sinus pressure
n the control group during LAD ligation was 8  2.35 mm
g. Comparison of the arterial pressure after LAD ligation
howed no difference between groups. To avoid negative
ide effects of coronary outflow impedance, we timed cor-
nary sinus occlusion according to systolic venous pressure
ncrease. This is in accordance with the hypothesis that
ntermittent coronary sinus occlusion has to be adjusted to
ndividual pressures to optimize its effectiveness and avoid
rolonged periods of an increase of coronary inflow imped-
nce, which is a severe counteractive and unwanted side
ffect of coronary venous pressure increase. Normally, pro-
onged and fixed timings of coronary sinus occlusion with
ubsequent increments in venous outflow impedance lead to
hanges in arterial inflow. It is known that prolonged cor-
nary sinus occlusion induces arterial hypotension as well
s bradycardia owing to excessive impedance increments g
584 The Journal of Thoracic and Cardiovascular Surgery ● Junor arterial inflow, effects that were not found in this set of
xperiments. The implementation of an automatic feedback
ontrol of coronary venous pressure elevations restricted
hese side effects of coronary sinus reflexes and improved
egional perfusion, which even resulted in a tendency to-
ard higher pressures and stable hemodynamics in the
ICSO group.
Measurements of the ejection fraction as estimate of
lobal myocardial function are depicted in Figure E1. Ven-
ricular dimensions and volumes during the time course
f the experiment are depicted in Figures E2 to E5. Al-
hough the number of animals allows only a limited inter-
retation, the data suggest that global contraction was pre-
erved in PICSO-treated animals as compared with controls
although function declined in both groups, a statistically
ignificant decrease could be observed only in the control
roup).
atterns of Gene Expression and Tissue Distribution
f Transcripts
e tested the hypothesis that VEGF, an endothelial cell
itogen and a major regulator of angiogenesis, is upregu-
ated in response to intermittent occlusion of the coronary
inus. In PICSO-treated animals, a statistically significant up-
egulation of VEGF expression was observed (Figure E6). In
ll areas investigated, a transcriptional upregulation of
EGF was seen by an average VEGF/2-M ratio that was
t least 2.4 times higher than in controls.
The median (range) HO-1/2M ratio in the remote area
as 3.1 (1.1-8.5) in the control group and 5.4 (4.1-8.3) in
he PICSO group. In the PICSO group, a statistically sig-
ificant (P  .001) upregulation of HO-1 transcription of
bout 6-fold was induced in the infarcted myocardium in
omparison with the control group (Figure E7). In contrast
o the expression pattern of VEGF, no significantly different
hange of HO-1 transcription was observed in the border
reas of differently treated animals, thus indicating the
nvolvement of a quantitative difference in the mechano-
ensitive signaling mechanism.
Electrophoretic mobility shift assays of extracts isolated
rom myocardial specimens showed no differences in bind-
ng of HIF-1 to the consensus sequence between PICSO-
reated animals versus controls (Figure E8).
To determine the interrelationship between transient sys-
olic pulsation of the coronary sinus and the transcriptional
pregulation of HO-1 and VEGF, we performed a correla-
ion analysis. As shown in Table E2, a positive and statis-
ically significant correlation between both mean and devel-
ped peak coronary sinus pressure and the HO-1 and VEGF
ene transcription was found. These findings strongly sug-
est that mechanical strain and stretch produced by the
ulsatile action of the reflowing blood in the deprived
enous vasculature trigger the activation of a genomic pro-
ram within the myocardium.
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Piscussion
ajor Findings
ICSO effects and their comparison with clinically applied
ethods of myocardial protection are well established.15,16
s reported in the literature on mechanotransduction, the
ntentional activation of venous endothelium by PICSO
nduced angiogenic cascades.8-10,17 As anticipated, the ef-
ect of the pressure increase in the coronary venous circu-
ation influenced the local expression of our exemplary
ignaling molecules HO-1 and VEGF in porcine myocar-
ium, whereas the HIF pathway remained unchanged. This
ight not be restricted to the endothelium inasmuch as
nterstitial fluid flow from the bloodstream to the media
ransmits shear stress to the smooth muscle cells.17
HO-1 catabolizes heme into three products: carbon mon-
xide, biliverdin (which is rapidly converted to bilirubin),
nd free iron (which leads to the induction of ferritin, an
ron-binding protein). HO-1 serves as a protective gene by
irtue of the anti-inflammatory, antiapoptotic and antipro-
iferative actions of one or more of these three products.18,19
akkisto and associates20 demonstrated that the expression
f HO-1 mRNA is induced after myocardial infarction in
ats mainly in the infarct border area. This was accompanied
y increased HO-1 protein in the cardiomyocytes of the
eri-infarct border areas and in the vascular structures
hroughout the myocardium. These observations indicate a
unction for HO-1 in maintaining vascular homeostasis and
erfusion in the surrounding areas of infarction by carbon
onoxide–induced vasodilatation and inhibition of platelet
ggregation. The importance of HO-1 as a defense mecha-
ism against ischemia/reperfusion injury is supported by the
ndings of Yet and associates,21 who showed increased
poptosis around the infarcted area in hearts of HO-1
nockout mice. Besides its direct effects, HO-1 appears to
e required for the action and induction of several other
olecules, for example, VEGF. Accordingly, it was shown
hat activation or overexpression of HO-1 augments the
ynthesis of VEGF in vascular smooth muscle cells and in
icrovascular endothelium.22-25 A recent study demon-
trated that transfer of HO-1 cDNA into endothelial cells
esults in a 2-fold increase in blood vessel formation.25 In-
uction of HO-1 or supplementation of cells with carbon
onoxide–releasing compounds results in increased formation
f capillaries.18,22-24 These observations indicate that HO-1 is,
n addition to its antiapoptotic and anti-inflammatory proper-
ies, a proangiogenic factor. The angiogenic response of
ndothelial cells to overexpression of the HO-1 gene pro-
ides direct evidence that the induction of HO-1 after injury
epresents an important tissue adaptive mechanism for mod-
rating the severity of cell damage produced in inflamma-
ory reaction sites of ischemia. Furthermore, it was shown
hat HO-1 promotes VEGF-driven angiogenesis that facili-
ates tissue repair.17 Wagner and associates26 reported that P
The Journal of Thoracicemodynamic forces induce the expression of HO-1 and
arbon monoxide production in cultured vascular smooth
uscle cells, whereas nitric oxide synthase expression and
itric oxide production were not influenced. On the other
and, Bussolati and coworkers27 provided evidence that
EGF induces prolonged HO-1 expression and activity in
uman endothelial cells.
Upregulation of VEGF and HO-1 gene expression in
ypoxic and ischemic tissues is a widely known reaction
nd compensatory effect. Significant improvements in cap-
llary density have also been observed with ischemic pre-
onditioning, but clinical practicability in acute coronary
yndromes is limited. In addition, numerous studies showed
olecular changes of mechanotransduction on the activa-
ion of endothelium as well as subsequent cascades, sup-
osedly leading toward recovery of jeopardized myocar-
ium. Again, most of the methods inducing mechanical
ower are difficult to apply clinically or are even impracti-
al.1 In the present study, we report on a clinically feasible
ethod, able to strongly upregulate HO-1 gene expression
n the infarct area of PICSO-treated animals, together with
n enhanced transcription of VEGF in infarct and border
reas as observed in untreated controls. The statistically
ignificant correlation (P  .01) of coronary sinus pressure
nd the expression of HO-1 and VEGF mRNA indicates
hat the transient occlusion of the coronary sinus with its
ubsequent elevation of venous pressure and pressurization
f the venous microcirculation is, in addition to ischemia, an
mportant stimulus for the manifold expression. With re-
pect to the short duration of the experiments, an enhanced
rotein expression might not have been detectable and is a
imitation of the study. The tendency in treated animals to
onserve global hemodynamics and ventricular dimensions,
reduced infarct size, and a preservation of functional
arameters in PICSO-treated animals are positive reactions
o this method, although the mechanism might not only be
elated to the angiogenic pulses observed, but rather caused
y a vasodilatatory effect of these molecules and an en-
ancement of collateral circulation, especially in border
ones.22
Sharma, Das, and Verdouw28 examined the expression of
O-1 in the heart during occlusion and subsequent reper-
usion of the LAD in pigs. In the distribution territory of the
AD, the expression of HO-1 was significantly increased
1.9-fold) compared with that of the area perfused by the left
ircumflex coronary artery (control). The authors suggested
hat the myocardial adaptive response to ischemia involves
pregulation of HO-1, indicating that this enzyme may
articipate in regulating the vascular tone via carbon mon-
xide and thereby contribute to an important defense
echanism in the heart. In our study we found a 4-fold
pregulated expression of HO-1 in the infarct area of
ICSO-treated animals, which indicates that the temporary
and Cardiovascular Surgery ● Volume 133, Number 6 1585
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CSPcclusion of the coronary sinus is an additional stimulus for
O-1 transcription. As a consequence, a carbon monoxide–
ediated vasodilatory response and improved perfusion in
he ischemic area from its borders should occur. Besides the
pregulation of HO-1 mRNA in the area of myocardial
nfarction, we found that PICSO further enhances the tran-
cription of VEGF in both infarct and border areas and
xceeds the known increase induced by hypoxia by at least
.4-fold. VEGF is an endothelium-specific cell mitogen
inked with vessel development during embryonic develop-
ent. VEGF is produced in tissues acquiring new capillary
etworks; in adult tissues, expression of VEGF is increased
y hypoxia and tissue ischemia. In myocardial infarction,
nduction of VEGF may serve as a signal for physiologi-
ally necessary compensatory angiogenesis, which may
meliorate the effects of hypertrophy and remodeling. Re-
ent reports on the acute induction of collateralization of
schemic myocardium by PICSO seem to corroborate the
otion that vasodilatory effects might be involved.29
In a rat myocardial infarction model of angiogenesis, Li
nd colleagues30 observed increased VEGF expression in
he areas of the left ventricle remote from the infarct area, as
ell as in the right ventricular myocardium, and postulated
hat a nonischemic or nonhypoxic stimulus was responsible
or the observed induction of VEGF expression. Intermit-
ent coronary venous pressure increase seems to act accord-
ngly via the pressurization of the endothelial cytoskeleton
nd most probably via pericytes.
Venous endothelial cells are subjected to mechanical
orces, including shear stress, pressure, and stretch, which
lter their functional and structural properties.31 Compared
ith shear stress, pulsatile stress on endothelial cells pro-
uces a “two order of magnitude” effectiveness. So far, the
ffects of mechanical forces on the endothelium have not
een discriminated between arterial and venous microcircu-
ation. It can be expected that mechanotransduction of ve-
ous endothelium will be the target of future research be-
ause of its unique properties in immune defense and
egeneration. Zheng and associates32 demonstrated that
EGF transcription is upregulated in coronary microvascu-
ar endothelial cells, not only via paracrine signals from
tretched cardiac myocytes but also via an autocrine
ignaling from stretched endothelial cells. Our interven-
ion mainly increases pressure in the venous vasculature,
efilling the erectile function of the transmural veins and
eopening collateral microcirculation in the border zones by
he squeezing action of the remaining normally functioning
yocardium, but also via a molecular cascade that induces
asodilatation and subsequent acute collateralization.29
Paradigm Change in Coronary Sinus Interventions
ur findings suggest that a biomechanical intervention us-ng the abrupt change in venous flow and pressurization of d
586 The Journal of Thoracic and Cardiovascular Surgery ● Junhe backed-up blood cushion in the venous capacitance
nduces a genomic program that ameliorates the effects of
yocardial injury during coronary occlusion by the upregu-
ation of anti-inflammatory, antioxidative, vasodilatory, and
roangiogenic processes, thus enhancing the salvaging pro-
ess, and by inducing long-lasting effects on the structural
nd functional integrity of the former ischemic zone. This
ight be the molecular starting point leading to the struc-
ural changes of increased vessel density seen in early
xperimental retroperfusion studies. This represents a par-
digm change in the perception of retroperfusion techniques
nd a starting point in the awareness of beneficial effects
nd applications of this intervention. On the one hand, this
ay represent a promising therapeutic strategy for neovas-
ularization in ischemic heart diseases free of ethical con-
erns, immune reaction, or the risk of malignancy. On the
ther hand, it warrants new clinical trials, such as extending
oronary sinus interventions in a PISCO mode after global
rrest in the early reperfusion mode or as analog to ischemic
reconditioning in off-pump surgery. Komamura, Mishima,
nd Kodama1 presented a series of patients with acute
yocardial infarction and lysis therapy and found that 40
inutes of intermittent coronary sinus occlusion had a long-
asting effect, significantly reducing the incidence of major
dverse cardiac events in the treated group over a period of
years. In contrast to autotransplantation of cells into an
nfamiliar environment, PICSO induces a local environ-
ental change resulting in activation and many-fold in-
rease of proangiogenic gene expression within the heart as
ompared with controls. It can be speculated that this ge-
etic reprogramming according to environmental changes
ay recruit stem cells, represents a form of “regional em-
ryonalization,” and may induce quasidevelopmental mat-
rations of jeopardized myocardium. The long-term effects
bserved clinically and the structural changes seen by Hahn
nd Kim6 are in agreement with the starting point of mo-
ecular changes, related to the pressure changes in the ve-
ous circulation during PICSO presented in this study.
Transient elevation of coronary venous pressure and
ICSO has been proven valid to salvage ischemic myocar-
ium, to induce washout of toxic metabolites, and to im-
rove regional myocardial blood flow and function. Our
resent findings on the release of angiogenic pulses suggest
hat, together with established beneficial results, there is a
econd window of myocardial protection leading to a long-
erm change. Recent reports from Nishida and coworkers2
n the use of mechanical force show equivalent effects on
ew vessel development through the application of shock
aves on ischemic myocardium.
There are currently patients recruited for the Cellwave
tudy (Combined Extracorporal Shock Wave Therapy and
ntracoronary Cell Therapy in Chronic Ischemic Myocar-
ium) to evaluate the application of shock waves as a
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Pethod to help to improve the homing of stem cells in
hronically ischemic areas.33 In analogy, it can be specu-
ated that periodic activation of venous endothelium through
ICSO induces long-lasting effects on the healing process
nd eventually the functional recovery of the heart, recapit-
lating the environmental processes during organogenesis.
onclusions
ur observation sheds light on the historic findings closing
he cycle of scientific perception and opening a new, clini-
ally feasible track to study the biological cause of applying
ontrolled stresses to venous endothelium. These data pro-
ide strong evidence in support of the concept that local
hanges in endothelial tissue structure and mechanics re-
ulting from hemodynamic force contribute significantly to
evelopmental as well as regenerative response and might
epresent the notion “Beck and back” presented by Dwight
. Harken,34 who as a surviving contemporary of Beck
nded this lecture quoting a phrase accredited to Sir Isaac
ewton: “We see so far because we stand on the shoulders
f giants.”
This report is dedicated to our mentors and teachers in cardio-
horacic surgery and experimental medicine, Prof Dr E. Wolner
nd Prof Dr Udo Losert, on the occasion of their 65th birthdays.
eferences
1. Komamura K, Mishima M, Kodama K. Preliminary clinical experi-
ence with intermittent coronary sinus occlusion in combination with
thrombolytic therapy in acute myocardial infarction. Jpn Circ J. 1989;
53:1152-63.
2. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al.
Extracorporeal cardiac shock wave therapy markedly ameliorates isch-
emia-induced myocardial dysfunction in pigs in vivo. Circulation.
2004;110:3055-61.
3. Kanamori T, Watanabe G, Yasuda T, Nagamine H, Kamiya H, Ko-
shida Y. Hybrid surgical angiogenesis omentopexy can enhance myo-
cardial angiogenesis induced by cell therapy. Ann Thorac Surg. 2006;
81:160-8.
4. O Shaughnessy L. Experimental methods of providing collateral cir-
culation to the heart. Br J Surg. 1936;23:665-70.
5. Syeda B, Schukro C, Heinze G, Modaressi K, Glogar D, Maurer G,
et al. The salvage potential of coronary sinus interventions: meta-
analysis and pathophysiologic consequences. J Thorac Cardiovasc
Surg. 2004;127:1703-12.
6. Hahn RS, Kim M. Revascularization of the heart. Histologic changes
after arterialization of the coronary sinus. Circulation. 1952;5:810-5.
7. Pearson H. The heart of the matter. Nat Med. 2004;10:445-6.
8. Helmke BP. Molecular control of cytoskeletal mechanics by hemody-
namic forces. Physiology (Bethesda). 2005;20:43-53.
9. Li S, Huang NF, Hsu S. Mechanotransduction in endothelial cell
migration. J Cell Biochem. 2005;96:1110-26.
0. Heil M, Schaper W. Influence of mechanical, cellular, and molecular
factors on collateral artery growth (arteriogenesis). Circ Res. 2004;95:
449-58.
1. Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF
expression in the heart. J Clin Invest. 1997;100:18-24.
2. Seko Y, Seko Y, Takahashi N, Shibuya M, Yazaki Y. Pulsatile stretch
stimulates vascular endothelial growth factor (VEGF) secretion by
cultured rat cardiac myocytes. Biochem Biophys Res Commun. 1999;
254:462-5.3. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of
serial measurements in medical research. Br Med J. 1990;300:230-5.
The Journal of Thoracic4. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials
with baseline and follow up measurements. Br Med J. 2001;323:
1123-4.
5. Lazar HL. Advantages of pressure-controlled intermittent coronary
sinus occlusion over left ventricle–powered coronary sinus retroper-
fusion. Ann Thorac Surg. 2001;71:402.
6. Lazar H. Coronary sinus retroperfusion: can forward progress still be
achieved by using a backward technique? J Thorac Cardiovasc Surg.
2004;127:1549-52.
7. Dulak J, Motterlini R, Huk I, Pachinger O, Weidinger F, Jozkowicz A.
Carbon monoxide and iron, by-products of heme oxygenase, modulate
vascular endothelial growth factor synthesis in vascular smooth muscle
cells. In: Abraham NG, editor. Physiology and pathology of heme
oxygenase. New York: Kluwer; 2002. p. 97-107.
8. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1:
unleashing the protective properties of heme. Trends Immunol. 2003;
24:449-55.
9. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, et al.
Carbon monoxide has anti-inflammatory effects involving the mitogen-
activated protein kinase pathway. Nat Med. 2000;6:422-8.
0. Lakkisto P, Palojoki E, Bäcklund T, Saraste A, Tikkanen I, Voipio-
Pulkki LM, et al. Expression of heme oxygenase-1 in response to
myocardial infarction in rats. J Mol Cell Cardiol. 2002;34:1357-65.
1. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L,
et al. Hypoxia induces severe right ventricular dilatation and infarction
in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23-9.
2. Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R,
et al. Heme oxygenase and angiogenic activity of endothelial cells:
stimulation by carbon monoxide, inhibition by tin protoporphyrin-IX.
Antioxid Redox Signal. 2003;5:155-62.
3. Dulak J, Józkowicz A, Foresti R, Kasza A, Frick M, Huk I, et al. Heme
oxygenase activity modulates vascular endothelial growth factor syn-
thesis in vascular smooth muscle cells. Antioxid Redox Signal. 2002;
4:229-38.
4. Józkowicz A, Huk I, Nigisch A, Weigel G, Weidinger F, Dulak J.
Effect of prostaglandin-J2 on VEGF synthesis depends on the induc-
tion of heme oxygenase-1. Anioxid Redox Signal. 2002;4:577-85.
5. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of
human heme oxygenase into coronary endothelial cells potentially
promotes angiogenesis. J Cell Biochem. 1998;68:121-7.
6. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer
AI. Hemodynamic forces induce the expression of heme oxygenase
in cultured vascular smooth muscle cells. J Clin Invest. 1997;100:
589-96.
7. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard
DO, et al. Bifunctional role for VEGF-induced heme oxygenase-1
in vivo: induction of angiogenesis and inhibition of leukocytic infil-
tration. Blood. 2004;103:761-6.
8. Sharma HS, Das DK, Verdouw PD. Enhanced expression and local-
ization of heme oxygenase-1 during recovery phase of porcine stunned
myocardium. Mol Cell Biochem. 1999;196:133-9.
9. Mohl W, Kajgana I, Bergmeister, H, Rattay F. Intermittent pressure
elevation of the coronary venous system as a method to protect
ischemic myocardium. Interact Cardiovasc Thorac Surg. 2005;
4:66-9.
0. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M.
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model
of angiogenesis. Am J Physiol. 1996;270:H1803-11.
1. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell.
An endothelial paradigm. Circ Res. 1993;72:239-45.
2. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ.
Bradycardia-induced coronary angiogenesis is dependent on vas-
cular endothelial growth factor. Circ Res. 1999;85:192-8.
3. Cellwave Study: Combined extracorporal shock wave therapy and
intracoronary cell therapy in chronic ischemic myocardium.www.
clinicaltrials.gov_ClinicalTrials.gov Identifier: NCT00326989; 2006.
4. Harken DE. Beck and back. In: Mohl W, Faxon D, Wolner E, editors.
The Clinics of CSI. Reprinted in the Coronary Sinus Library, 2003.
Society of Coronary Sinus Interventions 2003. Vol 4. p. 3-12.
and Cardiovascular Surgery ● Volume 133, Number 6 1587
*
T
3
(
i
m
m
w
p
(
v
v
†
T
c
P
m
P
1
F
R
5
5
p
X
e
M
p
t
o
A
5
s

a
r
C
C
A
§
T
G
s
b
u
W
o
m
p
p
D
o
r
f
e
w
b
l
t
m
b
H
s
(
E
Cardiopulmonary Support and Physiology Weigel et al
1
CSPExperimental Design
he studies were carried out on 12 female pigs (Edelschwein,
0–35 kg). After premedication with 1.86 mg/kg acepromacine
Vanastress) plus 15 mg/kg ketamine (Ketavet), anesthesia was
nitiated with thiopentone sodium (Thiopental, 10 mg/kg), piritra-
id (Dipidolor, 15 mg), and pancuronium bromide (Pavulon, 4
g). After endotracheal intubation, anesthesia was maintained
ith 100 g · kg1 · h1 piritramid plus 6.6 g · kg1 · h1
ancuronium bromide in Ringer’s solution and propofol
Diprivan) 6 mg · kg1 · h1. The animals were ventilated with
olume-controlled oxygen and room air according to blood gas
alues.
Echocardiography
wo-dimensional and two-dimensionally guided M-mode echo-
ardiograms were performed on a subset of 2 controls and 4
ICSO-treated animals with a 5-MHz transducer at baseline, 30
inutes after induction of myocardial infarction, 30 minutes after
ICSO (at 60 minutes after myocardial infarction), and at 120 and
80 minutes after myocardial infarction.
‡The sequences of the used primers are as follows: HO-1
orward, 5=-CCT CTC GCT GGA AAA AAG GA-3=; HO-1
everse, 5=-AGG GCA CTG GCT GCA TGT-3=; VEGF Forward,
=-CCC ACG AAG TGG TGA AGT TCA-3=; VEGF Reverse,
=-CCA CCA GGG TCT CGA TTG G-3=. Primers and Taq Man
robes were designed according to GenBank: accession numbers
60677 and AF461807, respectively. Primers were designed to
xclude the amplification of genomic DNA. FAM-labeled Taq
an probes were used to detect the polymerase chain reaction
roduct. The probe sequences were designed to be complementary
o the target sequences of the HO-1 and VEGF gene. The sequence
f the HO-1 probe was as follows: 5=-TGT GGC ATC TTT CCC
AC CAA-3=. The sequence of the VEGF probe was as follows:
=-CGT CTA CCA GCG CAG CTA CTG CCG-3=. Target tran-
cripts were normalized to the endogenous housekeeping transcript
2-M. Primers and FAM-labeled Taq Man probe were designed
ccording to GenBank: accession number L13854. The sequences
ead as follows: 2-M Forward primer, 5=CCC CCG AAG GTT
AG GTT TA-3=; Reverse, 5=GCA GTT CAG GTA ATT TGG
587.e1 The Journal of Thoracic and Cardiovascular Surgery ● JTT TC-3=; Taq Man probe, 5=TCA CGC CAC CCA GCG GAA
AC-3=.
DNA Binding Reaction
he double-stranded blunt-ended HIF-1 (5= GCC CTA CGT
CT GTC TCA 3=) consensus oligonucleotide was customer-
ynthesized by VBC-GENOMICS (Vienna, Austria) and end-la-
eled with -32P adenosine triphosphate (ICN Pharmaceuticals)
sing T4 polynucleotide kinase (Promega Corporation, Madison,
is). Unincorporated nucleotides were removed by centrifugation
ver a Sephadex G-25 spin column (Boehringer, Mannheim, Ger-
any). Binding reactions containing 14 g of nuclear extract, 1 g
oly(dI) poly(dC), and 103 cpm of -32P-labeled oligonucleotide
robe were incubated for 20 minutes at room temperature. Protein-
NA complexes were resolved by nondenaturing electrophoresis
n 4.5% (w/v) polyacrylamide slab gels. Gels were initially pre-
un in 1  Tris–glycine–ethylenediaminetetraaceitc acid buffer
or 30 minutes at 300 V; subsequent to loading of samples,
lectrophoresis was maintained at 300 V for 30 to 40 minutes. Gels
ere dried under vacuum and HIF-1 complexes were visualized
y autoradiography.
For competition experiments, a 100-fold mol/L excess of un-
abeled annealed oligonucleotides was added to the binding reac-
ion mixtures before addition of the labeled probes.
The specificity of DNA binding was further confirmed by a
utant oligo with a CGT ¡ AAA substitution in the HIF-1 DNA
inding motif (VBC-GENOMICS, Vienna, Austria) instead of the
IF-1 consensus oligonucleotide.
¶Table E1 shows a summary of the hemodynamic data mea-
ured in the control group (Table E1, A) and in the PICSO group
Table E1, B).
Averaged global hemodynamics are depicted in Table E1, C.
-Reference
E1. Force TL, Folland ED, Aebischer N. Echocardiographic assessment of
ventricular function. In: Marcus ML, Skorton DJ, Schelbert HR, Wolf
GL, editors: Cardiac imaging: a companion to Braunwald‘s heart
disease. Philadelphia: WB Saunders; 1991, p. 374-471.
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PABLE E1B. Hemodynamic data during normal perfusion, LAD occlusion, and PICSO
Time after LAD occlusion
Normal perfusion LAD occlusion 15 min 30 min 60 min 120 min 180 min
R 105.5 9.6 102.4 14.2 97.5 28.7 107.2 16.8 113.3 14.8 112.3 18.5 110.8 14.0
oP sys 113.0 6.0 105.2 10.8 91.2 16.8 95.3 10.1 96 11.0 92.3 8.5 95 5 10.0
oP dia 77.5 7.8 68.8 9.2 62.5 9.2 61.2 8.2 55.8  10 8 52.8 11.5 58.5 8.2
SP sys 19.8 4.0 17 5.0 46.3 19.9 57.0 14.3 54.5 16.9 50.3 12 3 49.3 14 1
SP dia 10.2 5.0 5.8  0.5 17.7 10.4 18.5 7.4 18.2  7.7 18 7.7 17.7  8.3
AD, Left anterior descending coronary artery; PICSO, pressure-controlled intermittent coronary sinus occlusion; HR, heart rate (beats/min); AoP, aortic
lood pressure (mm Hg); CSP, coronary sinus pressure; sys, systolic; dia, diastolic.
ABLE E1C. Averaged hemodynamic data during interven-
ion
PICSO Controls P value
R 109.0 18.0 97.8 20.1 .7
oP sys 93.8 10.1 88.4 9.5 .25
oP dia 57.9 8.4 56.7 6.2 .95
ICSO, Pressure-controlled intermittent coronary sinus occlusion; HR,
eart rate (beats/min); AoP, aortic blood pressure (mm Hg); sys, systolic;
TABLE E2. Correlation of myocardial gene expression and
CSP
Coefficient of
correlation Significance
VEGF–CSP peak 0.60 P  .01
VEGF–CSP mean 0.63 P  .01
HO-1–CSP peak 0.38 P  .01
HO-1–CSP mean 0.42 P  .01
CSP, Coronary sinus pressure; VEGF, vascular endothelial growth factor;
ABLE E1A. Hemodynamic data during normal perfusion and LAD occlusion without PICSO (control group)
Time after LAD occlusion
Normal perfusion LAD occlusion 15 min 30 min 60 min 120 min 180 min
R 97.2 18.9 103.2 28.5 97.4 29.5 99.0 23.0 99.6 20.1 100.0 14.5 93.8  29.2
oP sys. 111.2 11.3 106.0 11.6 88.6 14.3 91.0 11.7 92.2 9.0 87.0 11.9 84.5 1.3
oP dia. 73.2 10.8 65.2 11.3 60.6 13.3 61.0 12.9 56.8 13.9 58.0 4.1 46.0 8.3
SP sys. 10.0 0.0 10.0 0.0 7.5 3.5 7.5 3.5 7.0  2.8 7.0  2.8 7.0 2.8
SP dia. 4.0 1.4 4.0 1.4 3.0 0.00 3.0  0.0 4.0  1.4 4.0  1.4 4.0 1.4
AD, Left anterior descending coronary artery; PICSO, pressure-controlled intermittent coronary sinus occlusion; HR, heart rate (beats/min); AoP, aortic
lood pressure (mm Hg); CSP, coronary sinus pressure; sys, systolic; dia, diastolic.ia, diastolic. H
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CSPigure E1. Scatter plot of the ejection fraction of control and
ICSO group data with an observation period of about 180 min-
tes. In both groups, the ejection fraction decreases depending
n rinsing time (PICSO P < .06; control P < .004). The ejection
raction decrease was not statistically significant between the
roups (P  .08). PICSO, Pressure-controlled intermittent coro-
ary sinus occlusion.
Figure E2. Scatter plot of the mean end-diastolic dimension (EDD)
of control and PICSO group data with an observation period of
about 180 minutes. The mean EDD increases in both groups
depending on rinsing time, however without reaching statistical
significance. The mean EDD increase was not significantly dif-
ferent in the groups (P  .14). PICSO, Pressure-controlled inter-
mittent coronary sinus occlusion.587.e3 The Journal of Thoracic and Cardiovascular Surgery ● June 2007
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Pigure E3. Scatter plot of the mean end-systolic dimension (ESD)
f control and PICSO group data with an observation period of
bout 180 minutes. The mean ESD increases in both groups
epending on rinsing time, reaching statistical significance only
n the control group (P < .03). The mean ESD increase was not
ignificantly different between the groups (P  .21). PICSO, Pres-
ure-controlled intermittent coronary sinus occlusion.
Figure E4. Scatter plot of the end-diastolic volume (EDV) of con-
trol and PICSO group data with an observation period of about 180
minutes. The EDV increases in both groups depending on rinsing
time, reaching statistical significance in the PICSO group (P <
.03). The EDV increase was not significantly different between the
groups (P  .11). PICSO, Pressure-controlled intermittent coro-
nary sinus occlusion.The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 6 1587.e4
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CSPigure E5. Scatter plot of the end-systolic volume (ESV) of control
nd PICSO group data with an observation period of about 180
inutes. The ESV increases in both groups depending on rinsing
ime, reaching statistical significance in the PICSO group (P <
04). The ESV increase was not statistically significant between
he groups (P  .18). PICSO, Pressure-controlled intermittent
oronary sinus occlusion.
Figure E6. Expression of VEGF mRNA in different specimens of
remote, border, and infarcted areas of porcine myocardium. Tran-
sient pressurization of the coronary sinus (PICSO†) induces a
significant upregulation of VEGF expression compared with con-
trols (†). Student 2-sample t test on log-base-2 transformed data.
VEGF, Vascular endothelial growth factor; PICSO, pressure-con-
trolled intermittent coronary sinus occlusion.587.e5 The Journal of Thoracic and Cardiovascular Surgery ● June 2007
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igure E7. Expression of HO-1 mRNA in different specimens of
emote, border, and infarcted areas of porcine myocardium. Tran-
ient pressurization of the coronary sinus (PICSO†) induces a
ignificant upregulation of HO-1 expression in the infarcted area
ompared with controls (†). Student 2-sample t test on log-base-2
ransformed data. HO-1, heme oxygenase 1; PICSO, pressure-
ontrolled intermittent coronary sinus occlusion.
Figure E8. Representative electrophoretic mobility shift assay of
tissue extracts isolated from remote, border, and infarcted areas
of porcine myocardium. PICSO, Pressure-controlled intermittent
coronary sinus occlusion.The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 6 1587.e6
